Obesity News and Research

Latest Obesity News and Research

Obese white men with diabetes face worse outcomes following radical prostatectomy

Obese white men who have both diabetes and prostate cancer have significantly worse outcomes following radical prostatectomy than do men without diabetes who undergo the same procedure, according to research from Duke University Medical Center appearing in Cancer Epidemiology, Biomarkers & Prevention

12 Jan 2010

OAC to launch national weight and health awareness campaign

On January 18, 2010, the Obesity Action Coalition (OAC) will launch a national weight and health awareness campaign aimed to encourage the American public to assess their weight and urge them to speak to their doctor about their weight.

12 Jan 2010

Amarin commences enrollment in its AMR101 Phase 3 clinical trials for cardiovascular disease

Amarin Corporation plc, a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease, today announced that first patients were enrolled in the MARINE and ANCHOR Phase 3 clinical trials for AMR101, the Company's lead product candidate. These clinical trials are designed to demonstrate that AMR101 lowers triglyceride levels in patients with very high triglycerides (the MARINE Study) and high triglycerides in patients with mixed dyslipidemia being treated with statins (the ANCHOR Study).

11 Jan 2010

New data from phase 3 study of avanafil for treatment of ED announced

VIVUS, Inc. today announced new data from an analysis of the recently completed phase 3 study (REVIVE TA-301) of avanafil, an investigational drug candidate for the treatment of erectile dysfunction (ED).

11 Jan 2010

Arizona resident achieves weight-loss with Dr. Siegal's COOKIE DIET

Dr. Sanford Siegal developed the concept of a diet based on a hunger-controlling food in the early 1970s while writing a book about substances in food that are particularly satisfying of hunger.

9 Jan 2010

European Society of Cardiology warns public about risk factors involved in obesity, diabetes and hypertension

Following the sudden death yesterday of the former French government minister Philippe Séguin, who suffered a fatal heart attack, aged 66, the European Society of Cardiology is warning the public of the dangers of leaving risk factors such as hyperlipidemia, hypertension or diabetes untreated. Other major risk factors for coronary artery disease are smoking or being overweight.

9 Jan 2010

MinuteClinic re-accredited and earns the Joint Commission's Gold Seal of Approval

MinuteClinic, the retail health care division of CVS Caremark (NYSE: CVS) and the pioneer and largest provider of retail-based medical clinics in the United States, has become the first retail clinic to be re-accredited and earn the Joint Commission's Gold Seal of Approval(TM) for consecutive evaluation periods by having demonstrated compliance with The Joint Commission's national standards for health care quality and safety.

9 Jan 2010

Jamba Juice and CAHPERD join to introduce the 2010 Jamba Jump Day event

Jamba Juice Company and The California Association for Health, Physical Education, Recreation and Dance (CAHPERD) announced today its shared mission to keep California's children healthy and active with the 2010 Jamba Jump Day(TM) event -- a mass attempt to break the Guinness World Record for the "Most People Jumping/Skipping Rope at the Same Time".

8 Jan 2010

Scientists and clinicians address diagnosis and treatment for autoimmune and autoinflammatory diseases

Autoimmune and autoinflammatory diseases are a major health issue. The National Institutes of Health reports that up to 23.5 million Americans are afflicted. The American Autoimmune Related Diseases Association reports the number is closer to 50 million. Scientists and clinicians at The University of Texas Health Science Center at Houston can address the diagnosis and treatment of these conditions, as well as the latest advances in research.

8 Jan 2010

King Center to host second annual 'Health and Wellness Forum'

The King Center announced that it will officially launch the 2010 MLK Birthday Observance on Saturday, Jan. 9, 2010 by hosting and co-sponsoring its second annual “Health and Wellness Forum.” It is being co-sponsored by a $50,000 grant from Aetna, which also funded last year’s inaugural program.

8 Jan 2010

Cinergy Health offers tips to prevent and combat obesity

Cinergy Health, a nationwide agency for guaranteed issue and short term major medical insurance programs, responds to a new statistic that shows obesity outranks smoking as the main concern in healthcare.

8 Jan 2010

Final health care reform legislation requires comprehensive coverage of smoking cessation treatment

As Congress negotiates a final health care reform bill, lawmakers should seize this unprecedented opportunity to invest in proven measures that prevent costly diseases from occurring in the first place, which will improve health and reduce health care costs. These include measures to prevent and reduce tobacco use, which remains the leading cause of preventable death in the United States, killing more than 400,000 people and costing the nation $96 billion in health care expenditures annually.

8 Jan 2010

Phase 1 clinical trial of SIRT1 inhibitor for the treatment of Huntington’s Disease commenced

Elixir Pharmaceuticals, Inc. announced today that its partner, Siena Biotech S.p.A., has commenced Phase 1 clinical testing of Elixir’s potent, first-in-class SIRT1 (sirtuin-1) inhibitor for the treatment of Huntington’s Disease.

8 Jan 2010

Medtronic invests in GI Dynamics to advance treatment for metabolic disorders

GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced that it has received a strategic investment from Medtronic, Inc., the global leader in medical device technology and therapies designed to treat chronic diseases.

8 Jan 2010

Positive results from phase 2 study evaluating the safety and efficacy of Qnexa announced

VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.

7 Jan 2010

Biggest Loser implements MedGem indirect calorimeter to assess metabolic changes in program contestants

Microlife Medical Home Solutions, Inc. (MiMHS) announces The Biggest Loser medical staff will implement the MedGem indirect calorimeter to assess metabolic changes in program contestants. The MedGem handheld indirect calorimeter is an FDA-cleared, Class II, medical device that assesses metabolic rate by measuring a patient’s resting oxygen consumption.

7 Jan 2010

Authors explain why health care reform initiative should include CER

The current health care reform bills approved by the House and the Senate seek to expand health insurance coverage while containing costs; however, the proposed policy changes are not guaranteed to improve health for individuals or society, according to a "Perspective" article by faculty of Weill Cornell Medical College in the Jan. 6 New England Journal of Medicine.

7 Jan 2010

Balanced diet and exercise are the only reliable ways to lose weight

It's time to set the record straight. The only reliable way to lose weight is to eat less or exercise more. Preferably both.

7 Jan 2010

Survivors of pediatric cancer at greater risk for cardiovascular disease

Survivors of pediatric cancer are at greater risk for high cholesterol, diabetes and high blood pressure, all of which predispose them to heart disease. These risk factors for heart disease are being found at an earlier age than in the general population, according to research published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

7 Jan 2010

Toxic chemicals make us susceptible to a wide range of diseases

From the Industrial Revolution and onward, the world has become an environment that is overflowing with dangerous toxins. Mass manufacturing has resulted in thousands of chemical pollutants being released in the atmosphere, water, and soil. As well, there has been a widespread increase of chemicals being added to almost every type of food and retail product.

6 Jan 2010

Obesity News and Research

Latest Obesity News and Research

Obese white men with diabetes face worse outcomes following radical prostatectomy

OAC to launch national weight and health awareness campaign

Amarin commences enrollment in its AMR101 Phase 3 clinical trials for cardiovascular disease

New data from phase 3 study of avanafil for treatment of ED announced

Arizona resident achieves weight-loss with Dr. Siegal's COOKIE DIET

European Society of Cardiology warns public about risk factors involved in obesity, diabetes and hypertension

MinuteClinic re-accredited and earns the Joint Commission's Gold Seal of Approval

Jamba Juice and CAHPERD join to introduce the 2010 Jamba Jump Day event

Scientists and clinicians address diagnosis and treatment for autoimmune and autoinflammatory diseases

King Center to host second annual 'Health and Wellness Forum'

Cinergy Health offers tips to prevent and combat obesity

Final health care reform legislation requires comprehensive coverage of smoking cessation treatment

Phase 1 clinical trial of SIRT1 inhibitor for the treatment of Huntington’s Disease commenced

Medtronic invests in GI Dynamics to advance treatment for metabolic disorders

Positive results from phase 2 study evaluating the safety and efficacy of Qnexa announced

Biggest Loser implements MedGem indirect calorimeter to assess metabolic changes in program contestants

Authors explain why health care reform initiative should include CER

Balanced diet and exercise are the only reliable ways to lose weight

Survivors of pediatric cancer at greater risk for cardiovascular disease

Toxic chemicals make us susceptible to a wide range of diseases

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Obesity News and Research

Latest Obesity News and Research

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in